381 related articles for article (PubMed ID: 24736453)
1. MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration.
Cebrián C; Zucca FA; Mauri P; Steinbeck JA; Studer L; Scherzer CR; Kanter E; Budhu S; Mandelbaum J; Vonsattel JP; Zecca L; Loike JD; Sulzer D
Nat Commun; 2014 Apr; 5():3633. PubMed ID: 24736453
[TBL] [Abstract][Full Text] [Related]
2. Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: Possible role of chronic stress in the onset of Parkinson's disease.
Sugama S; Sekiyama K; Kodama T; Takamatsu Y; Takenouchi T; Hashimoto M; Bruno C; Kakinuma Y
Brain Behav Immun; 2016 Jan; 51():39-46. PubMed ID: 26291405
[TBL] [Abstract][Full Text] [Related]
3. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.
Farrand AQ; Helke KL; Gregory RA; Gooz M; Hinson VK; Boger HA
Brain Stimul; 2017; 10(6):1045-1054. PubMed ID: 28918943
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of α-synuclein in aged human brain associated with neuromelanin accumulation.
Xuan Q; Xu SL; Lu DH; Yu S; Zhou M; Uéda K; Cui YQ; Zhang BY; Chan P
J Neural Transm (Vienna); 2011 Nov; 118(11):1575-83. PubMed ID: 21461961
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates.
Purisai MG; McCormack AL; Langston WJ; Johnston LC; Di Monte DA
Neurobiol Dis; 2005 Dec; 20(3):898-906. PubMed ID: 16006134
[TBL] [Abstract][Full Text] [Related]
7. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
[TBL] [Abstract][Full Text] [Related]
8. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
Herrero MT; Hirsch EC; Kastner A; Ruberg M; Luquin MR; Laguna J; Javoy-Agid F; Obeso JA; Agid Y
Neuroscience; 1993 Sep; 56(2):499-511. PubMed ID: 8247275
[TBL] [Abstract][Full Text] [Related]
9. Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra.
Mori F; Nishie M; Kakita A; Yoshimoto M; Takahashi H; Wakabayashi K
J Neuropathol Exp Neurol; 2006 Aug; 65(8):808-15. PubMed ID: 16896314
[TBL] [Abstract][Full Text] [Related]
10. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
[TBL] [Abstract][Full Text] [Related]
11. Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson's Disease.
Alarcón-Arís D; Recasens A; Galofré M; Carballo-Carbajal I; Zacchi N; Ruiz-Bronchal E; Pavia-Collado R; Chica R; Ferrés-Coy A; Santos M; Revilla R; Montefeltro A; Fariñas I; Artigas F; Vila M; Bortolozzi A
Mol Ther; 2018 Feb; 26(2):550-567. PubMed ID: 29273501
[TBL] [Abstract][Full Text] [Related]
12. The role of alpha-synuclein in the development of the dopaminergic neurons in the substantia nigra and ventral tegmental area.
Tarasova TV; Lytkina OA; Roman AY; Bachurin SO; Ustyugov AA
Dokl Biol Sci; 2016; 466():5-7. PubMed ID: 27021360
[TBL] [Abstract][Full Text] [Related]
13. Lesioning noradrenergic neurons of the locus coeruleus in C57Bl/6 mice with unilateral 6-hydroxydopamine injection, to assess molecular, electrophysiological and biochemical changes in noradrenergic signaling.
Szot P; Knight L; Franklin A; Sikkema C; Foster S; Wilkinson CW; White SS; Raskind MA
Neuroscience; 2012 Aug; 216():143-57. PubMed ID: 22542679
[TBL] [Abstract][Full Text] [Related]
14. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury.
Kholodilov NG; Neystat M; Oo TF; Lo SE; Larsen KE; Sulzer D; Burke RE
J Neurochem; 1999 Dec; 73(6):2586-99. PubMed ID: 10582622
[TBL] [Abstract][Full Text] [Related]
16. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
17. Prothrombin kringle-2 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation.
Kim SR; Chung ES; Bok E; Baik HH; Chung YC; Won SY; Joe E; Kim TH; Kim SS; Jin MY; Choi SH; Jin BK
J Neurosci Res; 2010 May; 88(7):1537-48. PubMed ID: 20025058
[TBL] [Abstract][Full Text] [Related]
18. Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions.
Elstner M; Müller SK; Leidolt L; Laub C; Krieg L; Schlaudraff F; Liss B; Morris C; Turnbull DM; Masliah E; Prokisch H; Klopstock T; Bender A
Mol Brain; 2011 Dec; 4():43. PubMed ID: 22188897
[TBL] [Abstract][Full Text] [Related]
19. Dopamine and α-synuclein dysfunction in Smad3 null mice.
Tapia-González S; Giráldez-Pérez RM; Cuartero MI; Casarejos MJ; Mena MÁ; Wang XF; Sánchez-Capelo A
Mol Neurodegener; 2011 Oct; 6():72. PubMed ID: 21995845
[TBL] [Abstract][Full Text] [Related]
20. A study on the protective role of doxycycline upon dopaminergic neuron of LPS-PD rat model rat.
Zhang GB; Feng YH; Wang PQ; Song JH; Wang P; Wang SA
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3468-74. PubMed ID: 26439044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
